Splicing it up: A variant of the N-type calcium channel specific for pain

被引：9

作者：

Zamponi, GW ^{[1
]}

McCleskey, EW

机构：

[1] Univ Calgary, Dept Physiol & Biophys Cellular, Calgary, AB T2N 4N1, Canada

[2] Univ Calgary, Mol Neurobiol Res Grp, Calgary, AB T2N 4N1, Canada

[3] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA

来源：

NEURON | 2004年 / 41卷 / 01期

关键词：

D O I：

10.1016/S0896-6273(03)00846-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

How would you make a drug that inhibits pain without side effects? The most obvious strategy for analgesia targets molecules that are expressed only on neurons used for pain. In this issue of Neuron, Bell et al. report a new splice variant of a calcium channel that controls neurotransmitter release and show that it is expressed primarily on nociceptors, the sensory neurons that trigger pain.

引用

页码：3 / 4

页数：2

共 50 条

[21] Novel N-type calcium channel blockers efficacious in animal models of chronic pain.
Snutch, T
Feng, ZP
Belardetti, F
Vanderah, T
Zamponi, GW
Porreca, F
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U1 - U2
[22] Recent Updates of N-Type Calcium Channel Blockers with Therapeutic Potential for Neuropathic Pain and Stroke
Yamamoto, Takashi
Takahara, Akira
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (04) : 377 - 395
[23] Alternative splicing of the Cav2.2 subunit:: a change in N-type calcium channel activity for which purpose?
Weiss, Norbert
JOURNAL OF PHYSIOLOGY-LONDON, 2007, 580 (02): : 361 - 362
[24] L-/N-type Calcium Channel Blockers and Proteinuria
Ando, Katsuyuki
CURRENT HYPERTENSION REVIEWS, 2013, 9 (03) : 210 - 218
[25] Novel series of pyrazolylpiperidine N-type calcium channel blockers
Subasinghe, Nalin L.
Wall, Mark
Winters, Michael P.
Qin, Ning
Lubin, Mary L.
Finley, Michael F.
Brandt, Michael R.
Neeper, Michael
Schneider, Craig R.
Colburn, Raymond
Flores, Christopher M.
Sui, Zhihua
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[26] Antiproteinuric effect of an N-type calcium channel blocker, cilnidipine
Tsuchihashi, T
Ueno, M
Tominaga, M
Kajioka, T
Onaka, U
Eto, K
Goto, K
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2005, 27 (08) : 583 - 591
[27] N-type Calcium Channel in the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Tokuhara, Naoki
Namiki, Kana
Uesugi, Mai
Miyamoto, Chihiro
Ohgoh, Makoto
Ido, Katsutoshi
Yoshinaga, Takashi
Yamauchi, Toshihiko
Kuromitsu, Junro
Kimura, Sadao
Miyamoto, Norimasa
Kasuya, Yoshitoshi
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (43) : 33294 - 33306
[28] A novel series of pyrazolylpiperidine N-type calcium channel blockers
Subasinghe, Nalin L.
Wall, Mark J.
Winters, Michael P.
Qin, Ning
Lubin, Mary Lou
Finley, Michael F. A.
Brandt, Michael R.
Neeper, Michael P.
Schneider, Craig R.
Colburn, Raymond W.
Flores, Christopher M.
Sui, Zhihua
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4080 - 4083
[29] Gβ structural determinants of N-type calcium channel modulation
Arnot, MI
Barr, W
Zamponi, GW
BIOPHYSICAL JOURNAL, 2002, 82 (01) : 25A - 26A
[30] Evolving therapeutic indications for N-type calcium channel blockers: from chronic pain to alcohol abuse
Belardetti, Francesco
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (05) : 791 - 802

← 1 2 3 4 5 →